GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Universe Pharmaceuticals Inc (NAS:UPC) » Definitions » Research & Development

Universe Pharmaceuticals (Universe Pharmaceuticals) Research & Development : $4.86 Mil (TTM As of Sep. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Universe Pharmaceuticals Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Universe Pharmaceuticals's Research & Development for the six months ended in Sep. 2023 was $2.59 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2023 was $4.86 Mil.


Universe Pharmaceuticals Research & Development Historical Data

The historical data trend for Universe Pharmaceuticals's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Universe Pharmaceuticals Research & Development Chart

Universe Pharmaceuticals Annual Data
Trend Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Research & Development
Get a 7-Day Free Trial 0.62 0.58 5.47 7.64 4.86

Universe Pharmaceuticals Semi-Annual Data
Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 5.16 0.14 7.50 2.27 2.59

Universe Pharmaceuticals Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $4.86 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Universe Pharmaceuticals  (NAS:UPC) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Universe Pharmaceuticals Research & Development Related Terms

Thank you for viewing the detailed overview of Universe Pharmaceuticals's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Universe Pharmaceuticals (Universe Pharmaceuticals) Business Description

Traded in Other Exchanges
N/A
Address
265 Jingjiu Avenue, Economic & Technological Development Zone, Jinggangshan, Jiangxi, Ji’an, CHN
Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.

Universe Pharmaceuticals (Universe Pharmaceuticals) Headlines

From GuruFocus